FdaApplication

ANDA 215006

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSOMERSET THERAPEUTICS LLC
application_typeANDA
approval_date2024-12-18

Products (1)

ProductActive ingredientStrengthDosage form
OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDEEQ 0.2% BASESOLUTION/DROPS;OPHTHALMIC

1 product